Newsbenzinga
World's First End-To-End AI Drug Developer To Power Into Black On Lucrative Partnerships
· Published
Article summary
The developer of the world’s first end-to-end AI drug has projected a big leap in half-year earnings, driven by lucrative collaborations with multinationals image credit: Bamboo Works Key
An excerpt from the original article.
Comments —
Loading comments…